The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for ...

See more stories on Insider's business page. A third dose of Pfizer's coronavirus vaccine yields mild to moderate side effects, much like the second shot, according to data released this month by the ...

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused their meningiomas.

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

Both vaccines are administered in two doses and have similar effective rates. After the second dose, Pfizer’s vaccine is 95% effective, Moderna’s 94.5% effective but there are many differences. The ...

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

(Reuters Breakingviews) - Pfizer has made more than its share of value-destroying acquisitions. The pharmaceutical giant's $15 billion purchase of Hospira could reverse that history. The ...

WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...

ALBANY, N.Y. (NEWS10)- After months of anticipation, the Federal Food and Drug Administration (FDA) approved the use of Pfizer’s COVID-19 vaccine. On December 17 the FDA will vote to approve Moderna’s ...